A SAD Study of ZT002 Injection in Healthy Participants

Clinical trial NCT06423872 · COMPLETED

Trial details

NCT number: NCT06423872
Sponsor: Beijing QL Biopharmaceutical Co.,Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2023-06-19
Primary completion: 2023-10-20
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.